Table 2. Distribution of the HIV/AIDS cohort of HIV-infected patients based on age.
| eGFR | n (%) | |||||
|---|---|---|---|---|---|---|
| Total | <35a | 35–44a | 45–54a | 55–64a | 65≤a | |
| Stage 1 | 271 (59.7) | 82 (75.9) | 81 (65.8) | 72 (52.6) | 29 (43.9) | 7 (35.0) |
| Stage 2 | 159 (35.0) | 23 (24.1) | 37 (30.1) | 56 (40.9) | 31 (47.0) | 9 (45.0) |
| Stage 3a | 18 (4.0) | 0 (0.0) | 5 (4.1) | 6 (4.4) | 5 (7.6) | 2 (10.0) |
| Stage 3b | 4 (0.9) | 0 (0.0) | 0 (0.0) | 1 (0.7) | 1 (1.5) | 2 (10.0) |
| Stage 4 | 1 (0.2) | 0 (0.0) | 0 (0.0) | 1 (0.7) | 0 (0.0) | 0 (0.0) |
| Stage 5 | 1 (0.2) | 0 (0.0) | 0 (0.0) | 1 (0.7) | 0 (0.0) | 0 (0.0) |
| Total | 454 (100.0) | 108 (23.8) | 123 (27.1) | 137 (30.2) | 66 (14.5) | 20 (4.4) |
aAge
eGFR, estimated glomerular filtration rate; HIV, human immunodeficiency virus; CKD, chronic kidney disease; MDRD, modification of diet in renal disease; M, male; F, female.